Position in PTCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$87,393,690
-$53,938,520 QoQ
Shares Held
1,071,395
-48.4% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
2.42%
of 13F equity value
Holder Rank
#23
of 380 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Derivatives in PTCT
reported options exposure · as of Jun 30, 2026CallValue
$53,836,200
CallShares
660,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. PTCT ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
This page
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in PTCT
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,836,200 | 660,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $87,393,690 | 1,071,395 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,570,700 | 390,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $141,332,210 | 2,074,449 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $212,829,969 | 2,801,869 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $201,126,182 | 3,277,272 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $231,280,061 | 4,735,464 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $276,959,599 | 5,434,843 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $287,902,920 | 6,378,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $268,414,715 | 7,234,898 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $212,904,901 | 6,962,227 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $196,764,760 | 6,764,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $189,171,840 | 6,864,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $137,821,500 | 6,150,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $131,608,120 | 3,236,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $141,638,560 | 2,924,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $129,625,320 | 3,396,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $145,580,000 | 2,900,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $132,037,760 | 3,296,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $113,273,160 | 3,036,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $36,528,371 | 917,107 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $96,597,160 | 2,596,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $88,428,840 | 2,092,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $66,100,600 | 1,396,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,697,480 | 716,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $33,847,000 | 724,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,370,000 | 500,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $26,766,000 | 600,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||